We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GenMark Diagnostics Inc | NASDAQ:GNMK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.05 | 23.92 | 24.39 | 0 | 01:00:00 |
Delaware
|
|
27-2053069
|
(State or other jurisdiction
of incorporation)
|
|
(I.R.S. Employer
Identification No.)
|
5964 La Place Court
Carlsbad, California
|
(Address of principal executive offices, including zip code)
|
760-448-4300
|
(Registrant’s telephone number, including area code)
|
|
|
(Former Name or Former Address, if Changed Since Last Report)
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
1.
|
For the proposal to elect two nominees for director to serve a three-year term expiring at GenMark’s 2019 Annual Meeting of Stockholders, the voting results were as follows:
|
Name of Directors Elected
|
|
For
|
|
Withhold
|
|
Broker Non-Votes
|
Lisa M. Giles
|
|
35,390,074
|
|
265,635
|
|
4,545,959
|
Michael S. Kagnoff
|
|
27,747,173
|
|
7,908,536
|
|
4,545,959
|
2.
|
For the proposal to ratify Ernst & Young LLP as GenMark’s independent registered public accounting firm for the fiscal year ending December 31, 2016, the voting results were as follows:
|
For
|
|
Against
|
|
Abstain
|
40,179,188
|
|
9,979
|
|
12,501
|
3.
|
For the proposal to approve, on an advisory basis, the compensation of GenMark’s named executive officers, the voting results were as follows:
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
28,474,453
|
|
7,013,170
|
|
168,086
|
|
4,545,959
|
1 Year GenMark Diagnostics Chart |
1 Month GenMark Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions